From overtreatment to precision: a new clinical standard for DCIS management

Ductal carcinoma in situ (DCIS) remains one of the most conceptually challenging diagnoses in breast oncology. DCIS is technically non-invasive, contained within the basement membrane, and lacks metastatic potential in its pure form. Yet patients are told that they have “breast cancer,” a term